Shopping Cart 0
Cart Subtotal
USD 0

Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA (NAVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9

Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Navamedic Enters into Agreement with G. Pohl-Boskamp 11

Navamedic Enters into Agreement with bene-Arzneimittel 12

Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13

Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14

Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15

Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16

Navamedic Enters Into Distribution Agreement With Torrent Pharma 17

Navamedic Amends Distribution Agreement With Aspen Pharma 18

Equity Offering 19

Navamedic Raises USD1.3 Million in Private Placement of Shares 19

Navamedic ASA-Key Competitors 20

Navamedic ASA-Key Employees 21

Navamedic ASA-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Aug 24, 2018: Navamedic: Q2 2018 results 23

May 30, 2018: Navamedic Announces Q1 2018 results 24

Feb 15, 2018: Navamedic: Q4 2017 Results 25

Nov 10, 2017: Navamedic: Q3 2017 results 26

Jul 28, 2017: Navamedic ASA: Second quarter results 2017 27

Jul 28, 2017: Navamedic: Second quarter results 2017 28

May 10, 2017: Navamedic: Q1 2017 Results 29

Feb 15, 2017: Navamedic: Q4 2016 results 30

Corporate Communications 31

Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9

Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navamedic Enters into Agreement with G. Pohl-Boskamp 11

Navamedic Enters into Agreement with bene-Arzneimittel 12

Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13

Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14

Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15

Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16

Navamedic Enters Into Distribution Agreement With Torrent Pharma 17

Navamedic Amends Distribution Agreement With Aspen Pharma 18

Navamedic Raises USD1.3 Million in Private Placement of Shares 19

Navamedic ASA, Key Competitors 20

Navamedic ASA, Key Employees 21

Navamedic ASA, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Navamedic ASA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA (NAVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9

Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Navamedic Enters into Agreement with G. Pohl-Boskamp 11

Navamedic Enters into Agreement with bene-Arzneimittel 12

Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13

Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14

Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15

Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16

Navamedic Enters Into Distribution Agreement With Torrent Pharma 17

Navamedic Amends Distribution Agreement With Aspen Pharma 18

Equity Offering 19

Navamedic Raises USD1.3 Million in Private Placement of Shares 19

Navamedic ASA-Key Competitors 20

Navamedic ASA-Key Employees 21

Navamedic ASA-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Aug 24, 2018: Navamedic: Q2 2018 results 23

May 30, 2018: Navamedic Announces Q1 2018 results 24

Feb 15, 2018: Navamedic: Q4 2017 Results 25

Nov 10, 2017: Navamedic: Q3 2017 results 26

Jul 28, 2017: Navamedic ASA: Second quarter results 2017 27

Jul 28, 2017: Navamedic: Second quarter results 2017 28

May 10, 2017: Navamedic: Q1 2017 Results 29

Feb 15, 2017: Navamedic: Q4 2016 results 30

Corporate Communications 31

Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Navamedic ASA, Deals By Therapy Area, 2012 to YTD 2018 8

Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9

Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Navamedic Enters into Agreement with G. Pohl-Boskamp 11

Navamedic Enters into Agreement with bene-Arzneimittel 12

Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13

Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14

Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15

Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16

Navamedic Enters Into Distribution Agreement With Torrent Pharma 17

Navamedic Amends Distribution Agreement With Aspen Pharma 18

Navamedic Raises USD1.3 Million in Private Placement of Shares 19

Navamedic ASA, Key Competitors 20

Navamedic ASA, Key Employees 21

Navamedic ASA, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Navamedic ASA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.